ECILC EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment is involved in the production, marketing, and sale of medicines related to human health and veterinary medicines. The Real Estate Development segment engages in development of real estate properties; rental activities for serum facilities; and providing consulting services on land development and project management. The company was incorporated in 1951 and is based in Istanbul, Turkey. EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a subsidiary of Eczacibasi Holding A.S.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (IST: ECILC)
›
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (IST: ECILC) is listed on Borsa Istanbul, where its shares trade in TRY. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 891 employees.
The shares were at 45.90 TRY on 19 November 2026, down 44.9% over 52 weeks. Its 52-week range is 40.70 TRY to 132.60 TRY: the price is 65.4% below the high and 12.8% above the low.
Its market capitalisation is 31.45B TRY. It pays a dividend yielding 3.74% (it pays out 57% of its earnings), against a median of 1.90% among the dividend payers in that peer group.
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. reports return on equity of 3.4%, an operating margin of -3.8% and revenue down 18.0% year over year.
Its debt exceeds its cash by 1.88B TRY, a debt-to-equity ratio of 0.05. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.